These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Shain AH; Garrido M; Botton T; Talevich E; Yeh I; Sanborn JZ; Chung J; Wang NJ; Kakavand H; Mann GJ; Thompson JF; Wiesner T; Roy R; Olshen AB; Gagnon A; Gray JW; Huh N; Hur JS; Busam KJ; Scolyer RA; Cho RJ; Murali R; Bastian BC Nat Genet; 2015 Oct; 47(10):1194-9. PubMed ID: 26343386 [TBL] [Abstract][Full Text] [Related]
3. Desmoplastic Melanoma Carries High Mutation Burden. Cancer Discov; 2015 Nov; 5(11):OF1. PubMed ID: 26432107 [TBL] [Abstract][Full Text] [Related]
4. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation. Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085 [TBL] [Abstract][Full Text] [Related]
5. The Nuclear Protein IκBζ Forms a Transcriptionally Active Complex with Nuclear Factor-κB (NF-κB) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs. Kohda A; Yamazaki S; Sumimoto H J Biol Chem; 2016 Sep; 291(39):20739-52. PubMed ID: 27489104 [TBL] [Abstract][Full Text] [Related]
6. [Tert promoter mutations in melanoma: not only the MAP-kinase pathway]. Dereure O Ann Dermatol Venereol; 2013; 140(6-7):487-8. PubMed ID: 23773757 [No Abstract] [Full Text] [Related]
7. RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells. Mezzanotte JJ; Hill V; Schmidt ML; Shinawi T; Tommasi S; Krex D; Schackert G; Pfeifer GP; Latif F; Clark GJ Epigenetics; 2014 Nov; 9(11):1496-503. PubMed ID: 25482183 [TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. Shishodia S; Koul D; Aggarwal BB J Immunol; 2004 Aug; 173(3):2011-22. PubMed ID: 15265936 [TBL] [Abstract][Full Text] [Related]
9. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors. Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518 [TBL] [Abstract][Full Text] [Related]
10. A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells. Dhawan P; Richmond A J Biol Chem; 2002 Mar; 277(10):7920-8. PubMed ID: 11773061 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice. Imose M; Nagaki M; Naiki T; Osawa Y; Brenner DA; Asano T; Hayashi H; Kato T; Moriwaki H Liver Int; 2003 Oct; 23(5):386-96. PubMed ID: 14708901 [TBL] [Abstract][Full Text] [Related]
12. p28(GANK) associates with p300 to attenuate the acetylation of RelA. Ren YB; Luo T; Li J; Fu J; Wang Q; Cao GW; Chen Y; Wang HY Mol Carcinog; 2015 Dec; 54(12):1626-35. PubMed ID: 25400040 [TBL] [Abstract][Full Text] [Related]
13. Calcium-dependent regulation of the cell cycle via a novel MAPK--NF-kappaB pathway in Swiss 3T3 cells. Sée V; Rajala NK; Spiller DG; White MR J Cell Biol; 2004 Aug; 166(5):661-72. PubMed ID: 15326199 [TBL] [Abstract][Full Text] [Related]
14. Bai X; Kong Y; Chi Z; Sheng X; Cui C; Wang X; Mao L; Tang B; Li S; Lian B; Yan X; Zhou L; Dai J; Guo J; Si L Clin Cancer Res; 2017 Oct; 23(20):6120-6127. PubMed ID: 28720667 [No Abstract] [Full Text] [Related]
15. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B. Jeay S; Pianetti S; Kagan HM; Sonenshein GE Mol Cell Biol; 2003 Apr; 23(7):2251-63. PubMed ID: 12640111 [TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Huang S; DeGuzman A; Bucana CD; Fidler IJ Clin Cancer Res; 2000 Jun; 6(6):2573-81. PubMed ID: 10873114 [TBL] [Abstract][Full Text] [Related]
18. Drug discovery: How melanomas bypass new therapy. Solit D; Sawyers CL Nature; 2010 Dec; 468(7326):902-3. PubMed ID: 21164474 [No Abstract] [Full Text] [Related]
19. Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. Dhawan P; Singh AB; Ellis DL; Richmond A Cancer Res; 2002 Dec; 62(24):7335-42. PubMed ID: 12499277 [TBL] [Abstract][Full Text] [Related]
20. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]